U.S., March 6 -- ClinicalTrials.gov registry received information related to the study (NCT06858384) titled 'RAK-PRIDE: Optimizing Proton Pump Inhibitor Use Through Education and Intervention' on Feb. 16.
Brief Summary: The goal of this study is to determine if a pharmacist-led educational intervention can reduce the inappropriate use of proton pump inhibitors (PPIs) among adult patients (>=18 years) with potentially inappropriate PPI prescriptions in Ras Al Khaimah.
The main questions it aims to answer are:
* Can a pharmacist-led education program reduce unnecessary PPI use?
* Does the intervention improve patients' quality of life and reduce healthcare costs? Researchers will compare the intervention group (receiving pharmacist-led ed...